Psychiatric Genomics: An Update and an Agenda

The Psychiatric Genomics Consortium (PGC) is the largest consortium in the history of psychiatry. In the past decade, this global effort has delivered a rapidly increasing flow of new knowledge about the fundamental basis of common psychiatric disorders, particularly given its dedication to rapid progress and open science. The PGC has recently commenced a program of research designed to deliver “actionable” findings - genomic results that (a) reveal the fundamental biology, (b) inform clinical practice, and (c) deliver new therapeutic targets. This is the central idea of the PGC: to convert the family history risk factor into biologically, clinically, and therapeutically meaningful insights. The emerging findings suggest that we are entering into a phase of accelerated translation of genetic discoveries to impact psychiatric practice within a precision medicine framework.

Download data

• Downloaded 3,228 times
• Download rankings, all-time:
  • Site-wide: 1,507 out of 84,950
  • In genetics: 115 out of 4,455
• Year to date:
  • Site-wide: 30,482 out of 84,950
• Since beginning of last month:
  • Site-wide: 30,360 out of 84,950

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide